Runda Medical Plans to Acquire 12% of Hangzhou Yidan shares and 15% of Shanghai Ruimei shares for 115 Million Yuan

Shanghai Runda Medical Technology Co., Ltd. (Runda Medical) intends to buy a 12% stake of Hangzhou Yidan Biological Technology Co., Ltd. (Hangzhou Yidan) and a 15% stake of Shanghai Ruimei Computer Technology Co., Ltd. (Shanghai Ruimei) for 115 million yuan. This transaction will improve the ability of Runda Medical in information service.

Hangzhou Yidan is a service provider for medical laboratories in Zhejiang and mainly manages brands including Biomerieux, Oumeng, Radiometer and so on. The company is one of the largest dealers for Biomerieux in China.

Shanghai Ruimei is mainly engaged in the development and sales of medical laboratory information management software. Its core products are the Laboratory Information System (LIS) and Blood Transfusion Information System (BIS). The company is one of the leading companies of LIS in China and the acquisition of Shanghai Ruimei can improve the medical laboratory information service of Runda Medical.

Shanghai Runda Medical Technology Co., Ltd. was founded in 1999 and listed on the Shanghai Stock Exchange market since 2015 (A share code: 603108). It is dedicated to providing integrated medical laboratory services by offering various meaningful medical solutions, a full range of IVD products and professional technical support. The headquarter is located in Shanghai, with business and service covering the whole country.

Runda Medical owns more than 30 wholly-owned or holding subsidiaries spread across China, aims to expand geographic advantage in business development. And now Runda Medical has become a specialized company for product circulation and integrated service supply in the IVD market of China.

Currently, Runda Medical has provided comprehensive service solutions to hundreds of customers and gains high recognition from the market.